|
TIA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.202900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.15590000000243E-05 |
| Normal-vs-Stage2 |
7.632200E-01 |
| Normal-vs-Stage3 |
4.078400E-01 |
| Normal-vs-Stage4 |
2.195000E-01 |
| Stage1-vs-Stage2 |
3.383600E-03 |
| Stage1-vs-Stage3 |
2.057300E-03 |
| Stage1-vs-Stage4 |
4.010400E-01 |
| Stage2-vs-Stage3 |
3.548000E-01 |
| Stage2-vs-Stage4 |
1.943570E-01 |
| Stage3-vs-Stage4 |
4.455600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.156000E-03 |
| Normal-vs-AfricanAmerican |
2.962600E-01 |
| Normal-vs-Asian |
1.521520E-03 |
| Caucasian-vs-AfricanAmerican |
6.351200E-01 |
| Caucasian-vs-Asian |
9.709900E-02 |
| AfricanAmerican-vs-Asian |
1.405560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.019670E-03 |
| Normal-vs-Female |
1.581610E-02 |
| Male-vs-Female |
7.572000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31319999999258E-05 |
| Normal-vs-Age(41-60Yrs) |
3.699800E-02 |
| Normal-vs-Age(61-80Yrs) |
5.470600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.964200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.905790E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.117600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.020310E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.377400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.574160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.634600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.45959999999323E-05 |
| Classical-VS-Follicular |
7.244200E-03 |
| Classical-VS-Other |
3.189000E-01 |
| Classical-VS-Normal |
7.804900000008E-05 |
| Tall-VS-Follicular |
2.044000E-01 |
| Tall-VS-Other |
1.016610E-01 |
| Tall-VS-Normal |
4.002800E-01 |
| Follicular-VS-Other |
1.590190E-01 |
| Follicular-VS-Normal |
5.631000E-01 |
| Other-VS-Normal |
1.302590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.646300E-02 |
| Normal-vs-N1 |
1.619160E-03 |
| N0-vs-N1 |
1.605830E-02 |
|
|
